BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27077760)

  • 21. High fetal hemoglobin level is associated with increased risk of cerebral vasculopathy in children with sickle cell disease in Mayotte.
    Chamouine A; Saandi T; Muszlak M; Larmaraud J; Lambrecht L; Poisson J; Balicchi J; Pissard S; Elenga N
    BMC Pediatr; 2020 Jun; 20(1):302. PubMed ID: 32563256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.
    Uda M; Galanello R; Sanna S; Lettre G; Sankaran VG; Chen W; Usala G; Busonero F; Maschio A; Albai G; Piras MG; Sestu N; Lai S; Dei M; Mulas A; Crisponi L; Naitza S; Asunis I; Deiana M; Nagaraja R; Perseu L; Satta S; Cipollina MD; Sollaino C; Moi P; Hirschhorn JN; Orkin SH; Abecasis GR; Schlessinger D; Cao A
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1620-5. PubMed ID: 18245381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variant in the BCL11A (rs1427407), but not HBS1-MYB (rs6934903) loci associate with fetal hemoglobin levels in Indian sickle cell disease patients.
    Bhanushali AA; Patra PK; Nair D; Verma H; Das BR
    Blood Cells Mol Dis; 2015 Jan; 54(1):4-8. PubMed ID: 25457385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
    Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
    Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between four SNPs (rs7482144, rs4671393, rs28384513 and rs4895441) and fetal hemoglobin levels in Chinese Zhuang β-thalassemia intermedia patients.
    Lai Y; Zhou L; Yi S; Chen Y; Tang Y; Yi S; Yang Z; Wei H; Zheng C; He S
    Blood Cells Mol Dis; 2017 Mar; 63():52-57. PubMed ID: 28160732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.
    Mtatiro SN; Makani J; Mmbando B; Thein SL; Menzel S; Cox SE
    Am J Hematol; 2015 Jan; 90(1):E1-4. PubMed ID: 25263325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal hemoglobin in sickle cell anemia: molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans.
    Akinsheye I; Solovieff N; Ngo D; Malek A; Sebastiani P; Steinberg MH; Chui DH
    Am J Hematol; 2012 Feb; 87(2):217-9. PubMed ID: 22139998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.
    Sedgewick AE; Timofeev N; Sebastiani P; So JCC; Ma ESK; Chan LC; Fucharoen G; Fucharoen S; Barbosa CG; Vardarajan BN; Farrer LA; Baldwin CT; Steinberg MH; Chui DHK
    Blood Cells Mol Dis; 2008; 41(3):255-258. PubMed ID: 18691915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia
    Heitzer AM; Longoria J; Rampersaud E; Rashkin SR; Estepp JH; Okhomina VI; Wang WC; Raches D; Potter B; Steinberg MH; King AA; Kang G; Hankins JS
    Curr Res Transl Med; 2022 Jul; 70(3):103335. PubMed ID: 35303690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between Variants at BCL11A Erythroid-Specific Enhancer and Fetal Hemoglobin Levels among Sickle Cell Disease Patients in Cameroon: Implications for Future Therapeutic Interventions.
    Pule GD; Ngo Bitoungui VJ; Chetcha Chemegni B; Kengne AP; Antonarakis S; Wonkam A
    OMICS; 2015 Oct; 19(10):627-31. PubMed ID: 26393293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci.
    Leonardo FC; Brugnerotto AF; Domingos IF; Fertrin KY; de Albuquerque DM; Bezerra MA; Araújo AS; Saad ST; Costa FF; Menzel S; Conran N; Thein SL
    Br J Haematol; 2016 May; 173(3):456-60. PubMed ID: 26888013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.
    Neishabury M; Zamani F; Keyhani E; Azarkeivan A; Abedini SS; Eslami MS; Kakroodi ST; Vesiehsari MJ; Najmabadi H
    Blood Cells Mol Dis; 2013 Aug; 51(2):80-4. PubMed ID: 23541515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
    Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
    Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotypic Diversity among Angolan Children with Sickle Cell Anemia.
    Delgadinho M; Ginete C; Santos B; Miranda A; Brito M
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34069401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of BCL11A and HBS1L-MYB Genotypes in Sickle Cell Anemia.
    Qadah T; Noorwali A; Alzahrani F; Banjar A; Filimban N; Felimban R
    Indian J Hematol Blood Transfus; 2020 Oct; 36(4):705-710. PubMed ID: 33100714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HbF-promoting polymorphisms may specifically reduce the residual risk of cerebral vasculopathy in SCA children with alpha-thalassemia.
    Joly P; Bonello-Palot N; Badens C; Pissard S; Chamouine A; Bernaudin F; Bertrand Y; Connes P; Renoux C
    Clin Hemorheol Microcirc; 2021; 77(3):267-272. PubMed ID: 33216016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia.
    Vathipadiekal V; Farrell JJ; Wang S; Edward HL; Shappell H; Al-Rubaish AM; Al-Muhanna F; Naserullah Z; Alsuliman A; Qutub HO; Simkin I; Farrer LA; Jiang Z; Luo HY; Huang S; Mostoslavsky G; Murphy GJ; Patra PK; Chui DH; Alsultan A; Al-Ali AK; Sebastiani P; Steinberg MH
    Am J Hematol; 2016 Nov; 91(11):1118-1122. PubMed ID: 27501013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.
    Milton JN; Gordeuk VR; Taylor JG; Gladwin MT; Steinberg MH; Sebastiani P
    Circ Cardiovasc Genet; 2014 Apr; 7(2):110-5. PubMed ID: 24585758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of heme oxygenase-1(HMOX1) gene on fetal hemoglobin induction in sickle cell anemia patients.
    Hariharan P; Chavan V; Nadkarni A
    Sci Rep; 2020 Oct; 10(1):18506. PubMed ID: 33116199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fetal hemoglobin in sickle cell anemia: Bayesian modeling of genetic associations.
    Sebastiani P; Wang L; Nolan VG; Melista E; Ma Q; Baldwin CT; Steinberg MH
    Am J Hematol; 2008 Mar; 83(3):189-95. PubMed ID: 17918249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.